Clinical Trial Update: Targeting the Tumor Microenvironment in R/M SCCHN [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update focusing on tumor microenvironment in recurrent/metastatic squamous cell carcinoma of the head and neck.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: UNKNOWN